Announced Fri, 28 Aug, 2026 · 19:51 IST
EPL Q1 FY27 transcript filed; raises revenue growth guidance to high teens
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing
EPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.5%1-day move
₹251.53
prior close
₹253.72
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-0.6+0.1-0.3-4.5-5.1-2.1-1.6-1.1-2.2-6.0-6.2——
Up moveDown movePending
AI summary
EPL Q1 FY27 revenue up 25.3% YoY (20% underlying, excluding raw material price pass-through); EBITDA up 15.2% at 18.8% margin. Fifth straight quarter of double-digit growth. Beauty and Cosmetics and Oral Care both crossed 20% growth. Management raised revenue guidance to high teens from low double digits, holding underlying EBITDA margin guide at 20%. Indovida merger got CCI approval, on track. Europe margins targeted to recover to mid-teens range.
Likely market impact
Positive - raised growth guidance, consistent margin delivery despite cost pressure, Indovida merger advancing. Watch Europe margin recovery.